þ CD34 À , and CD8 þ CD34 À T cells from cord blood and from typical patients with T-cell-lineage acute lymphocytic leukemia and T-cell-lineage chronic lymphocytic leukemia in terms of expression and functions of CXCR5/CXCL13. We found that CXCR5 was selectively frequently expressed on T-cell-lineage acute (chronic) lymphocytic leukemia (T-ALL) CD8 þ CD34 þ T cells, but not on T-ALL CD4 þ CD34 þ , CD4 þ CD34 À , and CD8 þ CD34 À T cells. CXCR5 was rarely expressed on all types of CD34 þ and CD34 À CB or T-CLL T cells. CXCL13/B cells attracting chemokine 1 induced significant resistance to TNF-a-mediated apoptosis in T-ALL CD8 þ CD34 þ T cells, instead of induction of chemotactic and adhesive responsiveness. A proliferation-inducing ligand expression in T-ALL CD8 þ CD34 þ T cells was upregulated by CXCL13/BCA-1 (B-cell attracting chemokine 1). The CXCR5/CXCL13 pair by means of activation of APRIL (A proliferation-inducing ligand) induced resistance to apoptosis in T-ALL CD8 þ CD34 þ T cells in livin-dependent manner. In this process, cell-cell contact in culture was necessary. Based on our findings, we suggested that there were differential functions of CXCR5/CXCL13 in distinct types of cells. Normal lymphocytes, especially naı¨ve B and T cells, utilized CXCR5/CXCL13 for migration, homing, maturation, and cell homeostasis, as well as secondary lymphoid tissue organogenesis. Meanwhile, certain malignant cells took Introduction CXCR5 can be detected on mature B cells, small subsets of normal CD4 þ and CD8 þ T cells, skin-derived DCs, follicular DCs, and also other stromal cells (Fo¨rster et al., 1994; Gunn et al., 1998; Ansel et al., 2000; Saeki et al., 2000; Wu and Hwang, 2002; Yu et al., 2002) . CXCR5 is essentially responsible for guiding B cells into the B-cell zones of secondary lymphoid organs (Fo¨rster et al., 1996) , as well as for T-cell migration (Fo¨rster et al., 1996; Okada et al., 2002) . CXCR5, together with CCR7, controls lymphocyte and DC homing to secondary lymphoid organs and functions lymphoid organ organogenesis and organization (Reif et al., 2002; Ohl et al., 2003) . The CXCL13/B-cell attracting chemokine 1 (BCA-1), the only ligand for CXCR5 (Muller et al., 2003) , is responsible for compartmental homing of CXCR5-bearing B-lymphocytes and directing T-helper cells into the lymphoid follicle Finke et al., 2002) . CXCR5 is also highly expressed on vascular endothelium in the primary central nervous system lymphoma (Smith et al., 2003) , and in the mantle zone of all secondary lymphoid follicles in Hp-induced gastric mucosa-associated lymphoid tissue (Mazzucchelli et al., 1999) . However, the functional importance of CXCR5-CXCL13 in malignant T-cell trafficking, homing, and survival is not fully understood.
A common manifestation of T-cell-lineage acute and chronic lymphocytic leukemia (T-ALL and T-CLL) is infiltration of various organs by leukemic cells (Till et al., 2002) . CCR9 is selectively and functionally overexpressed on CD4 þ T cells from patients with T-ALL and T-CLL (Qiuping et al., 2003) . Despite these findings, little is known about the exact mechanisms and molecules regulate the homing, migration, inappropriate proliferation, and resistance to apoptosis of T-ALL and T-CLL T cells. The TNF family contains 16 members including TNF-a, lymphotoxin a, lymphotoxin b, CD40L, CD30L, CD27L, OX40L, 4-1BBL, FasL, TRAIL/APO-2 L, TL-1, TRANCE/RANKL, LIGHT, TWEAK, BLyS/BAFF, and a proliferation-inducing ligand (APRIL). APRIL is a rather new member of is family, named for its capacity to stimulate the proliferation of tumor cells in vitro (Hahne et al., 1998) . APRIL transcript levels are low in normal tissues. In contrast, higher mRNA levels have been detected in tumor cell lines and in a variety of primary tumor tissues (Kelly et al., 2000) . APRIL promotes tumor cell proliferation and resistance to apoptosis (Hahne et al., 1998; Kern et al., 2004) . A glioblastoma cell line is resistant to apoptosis by transfection with APRIL (Roth et al., 2001) . However, there are still contradictory findings with regard to its overall biological effects (Rennert et al., 2000) .
So far, eight human inhibitors of apoptosis proteins (IAPs) have been identified: c-IAP1, c-IAP2, NAIP, survivin, XIAP, Bruce, ILP-2, and livin. IAPs can block apoptosis mainly through their ability to bind and inhibit specific caspases such as caspase-3 and -7 (Chai et al., 2001; Riedl et al., 2001) . A novel IAP member, designated livin/ML-IAP/KIAP (Lin et al., 2000; Kasof and Gomes, 2001) , is suggested to mediate suppression of cell death (Sanna et al., 2002) . A key function of livin suggests that this protein may be an important target for immune-mediated tumor destruction (Schmollinger et al., 2003) . Except these points, little is known about the antiapoptotic effect of livin, and its regulatory mechanism.
Results

CXCR5 is selectively frequently expressed on T-ALL
þ T cells from patients with T-ALL were higher than that from
À T cells from T-ALL (a) and T-CLL (b) patients. The CD4 þ and CD8 þ T cells were freshly isolated and stained in triple colors of CD4 or CD8 (PE), CD34 (FITC), and CXCR5 (PerCP) as described in Materials and methods. The indicated numbers in the graphs were percentages of
The indicated percentages in the graphs were numbers of CXCR5 þ T cells. The data were from a single experiment, which was representative of 20 (T-ALL) and 15 (T-CLL) similar experiments performed. Isotype Ab controls were expressed as dished curves. CXCR5 expression on CD8 þ CD34 þ T cells was examined by real-time quantitative RT-PCR (c). The CD8 þ CD34 þ T cells were freshly isolated from CB of uncomplicated births, T-ALL, or T-CLL patients. In (c), a linear relationship between C T and log starting quantity of standard DNA template or target cDNA (CXCR5) was detected (data not shown). Bars show mean values7s.d. of eight similar experiments conducted Apoptotic resistance via CXCR5/livin/APRIL pathway Z Qiuping et al patients with T-CLL (Figure 1 ). Interestingly, CXCR5 was selectively frequently expressed on T-ALL CD8 þ CD34 þ T cells (89%) (Figure 1a ), whereas significantly lower on T-ALL CD4 CXCR5 (16 and 19%, respectively) (Figure 1b) . T-ALL CD8 þ CD34 À T cells expressed marginally but significantly higher frequent CXCR5 (28%) than that on T-ALL CD4 þ CD34 À T cells, and T-CLL CD4 þ CD34 À and CD8 þ CD34 À T cells (18, 17, and 10%, respectively) (Figure 1) . CXCR5 was at a rather low level on CD4
T cells from CB (Table 1) . CXCR3, CXCR4, and CXCR6 expression were either in agreement with previous reports or there were no differences among the three types of cell sources (Table 1) . CXCR5 mRNA was detected at very a low level in freshly isolated normal CB
þ T cells from normal CB and T-CLL patients (Figure 1c) . The same patterns of CXCR5 mRNA and protein expression in distinct cells were confirmed by Northern and Western blot (data not shown), as well as by immunofluorescence digital confocal microscopy (data not shown).
CXCL13 induces neither chemotaxis nor adhesion in
We studied the functional activity of CXCR5 on T-ALL CD4 þ CD34 þ and CD8 þ CD34 þ T cells. CXCL13 failed to induce chemotaxis and adhesion in freshly isolated T-ALL CD4 þ CD34 þ and CD8 þ CD34 þ T cells, whereas CXCL12, a ligand for CXCR4, had a significant chemotactic and adhesive effect on T-ALL CD4 þ CD34 þ T cell and T-ALL CD8 þ CD34 þ T cells (Figure 2 ). CXCL13 also failed to induce chemotaxis and adhesion in T-ALL CD4 þ CD34 À and CD8 þ CD34 À T cells (data not shown). Thus, the CXCR5-CXCL13 pair had no 'common' chemotactic and adhesive
By knowing that activation of CCR9 led to phosphorylation of GSK-3b and FKHR and provided a cell survival signal (Youn et al., 2001) , and that selective frequently CXCR5 expressed on T-ALL CD8 þ CD34 þ T cells, which had no 'common' chemotactic and adhesive functions in the cells, we examined the protective effects of CXCL13, CCL25, and CXCL12 on different types of cells on TNF-a-mediated apoptosis. The number of apoptotic and necrotic cells were significantly decreased on culture of T-ALL CD8 þ CD34 þ T cells in the presence of CXCL13 (Figure 3Am , n, and p). CXCL12 could rescue malignant cells (Figure 3Ag and h), as well as normal CB CD4 þ CD34 þ and CD8 þ CD34 þ T cells from TNF-a-mediated apoptosis (Figure 3Ae and f), in comparison with that in the untreated cells (Figure 3Aa , b, c, and d). Ab against CXCR5 could completely block the protective effect of CXCL13, indicating that rescuing effect was indeed induced by means of interaction of CXCL13 and CXCR5 (data shown in Figure 5 ). The observation was also confirmed in T-CLL Figure 3B , the total fractions of dead cells (including apoptotic and necrotic) in different types of the cells tested were the same patterns as the results in Figure 3A . These results could confirm the count effects of CXCR5 on death signaling of TNF-a in T-ALL CD8 þ CD34 þ T cells. We also measured CXCR4 ligand CXCL12 and CXCR5 ligand CXCL13 expression (Table 2 ). CXCL12 and CXCL13 were expressed in CD8 þ CD34 þ and CD8 þ CD34 À T-ALL cells. There was no difference in CXCL12 and CXCL13 expression between CB and T-ALL T cells.
cells (data not shown). As shown in
APRIL expression in T-ALL CD8 þ CD34 þ T
cells is selectively increased by CXCL13
We examined the expression levels of several members of TNF family on T-ALL CD8 þ CD34 þ T cells during the stimulation with CXCL13. Freshly isolated T-ALL CD8 þ CD34 þ T cells expressed low levels of APRIL (11%) (Figure 4a ). After a 24 h culture with CXCL13, the levels of APRIL expression could be significantly altered by 78%. Interestingly, level of the APRIL expression on normal CB CD8 þ CD34 þ T cells was unchanged after CXCL13 stimulation. Other examined members of the TNF family, for example, CD95, CD95L, and TRAIL were not changed ( Figure 4a ). APRIL mRNA was expressed at a very low level in freshly isolated T-ALL CD8 þ CD34 þ T cells ( Figure 4b ). It was significantly altered within 8 h after stimulation with CXCL13. The peak of expression appeared at 24 h. The same patterns of APRIL mRNA expression were confirmed in T-ALL CD8 þ CD34 þ T cells by Northern blot (Figure 4c ). Elevated APRIL protein expressions were also observed in T-ALL CD8 þ CD34 þ T cells by Western blot (Figure 4d ), confirming that CXCL13 selectively increased one member of the TNF family Figure 3 Analysis of apoptotic and total dead (necrotic and apoptotic) cells in CD4
cells. Flow cytometric analysis of apoptotic (A) and total dead cells (B). The CD8
þ CD34 þ T cells were freshly isolated from CB of uncomplicated births or T-ALL patients as described in Materials and methods, and were pretreated in the absence or presence of chemokine as indicated (all at 100 ng/ml) for 24 h at 371C, following stimulation with TNF-a (100 ng/ml) for 24 h at 371C. The cells were analysed by flow cytometry for PI-(y-axis) and FITC-conjugated annexin V (x-axis) as described in Materials and methods. The gating in the forward scatter and side scatter histograms was adhered to the lymphocyte region. The percentages of PI À annexin V þ cells and PI þ annexin V þ cells were indicated in the figure. The data (A) were from a single experiment, which was representative of six experiments performed. The data for total dead cells (PI (Pradet-Balade et al., 2002) , was expressed at a very low level in freshly isolated cells (Figure 4e ). TWE-PRIL mRNA expression was significantly increased within 16 h after stimulation with CXCL13. The peak of expression appeared at 24 h. The same patterns of TWE-PRIL mRNA expression were seen in T-ALL CD8 þ CD34 þ T cells by Northern blot (Figure 4f ). þ CD34 þ T cells were purified from T-ALL patients or CB of uncomplicated births (E) as described in Materials and methods, and were either freshly purified or treated in the presence of CXCL13 (at 100 ng/ml) for 24 h (or time intervals as indicated) at 371C. In (a), the cells were then stained with PE-labeled CD8mAb and appropriate Ab indicated as described in Materials and methods. The indicated numbers in the graphs were percentages of double-positive cells of CD8 and TNF family member protein as indicated. The data are from a single experiment, which is representative of six similar experiments performed. Isotype Ab controls were for a-APRIL, while other isotype Ab controls were not shown. In (b and e), the procedure for quantitative RT-PCR amplification was described in Materials and methods. A linear relationship between C T and log starting quantity of standard DNA template or target cDNA (APRIL and TWE-PRIL) was detected (data not shown). Bars show mean values7s.d. of six experiments conducted. In (c) and (f), the detection of mRNAs of APRIL and TWE-PRIL by Northern blot for CD8 þ CD34 þ T cells from T-ALL patients either freshly isolated or treated in the presence of CXCL13 (at 100 ng/ml) for time intervals as indicated. Total RNA from different cells were isolated, electrophoresed, and blotted as described in Materials and methods. The hybridization signals for APRIL or TWE-PRIL mRNA from different cells are shown in the upper panel. The 28S rRNAs in the lower panel confirm that comparable amounts of total RNA were used. In (d), the APRIL protein was examined using Western blot analyses. The cells, from T-ALL patients as described above, were lysed and total protein content electrophoresed and blotted as described in Materials and methods. Actins in the lower panel indicated the quantity of total cellular protein from the tested samples loaded in each lane. Arrows indicated markers used to verify equivalent molecular weights of appropriate proteins in each lane Apoptotic resistance via CXCR5/livin/APRIL pathway Z Qiuping et al CXCL13 (Figure 5Ab ). An Ab against APRIL was used to block APRIL after the cell stimulating with CXCL13, which could significantly increase APRIL expression. The Ab against APRIL could obviously inhibit apoptotic protection effect in T-ALL CD8 þ CD34 þ T cells by CXCL13 (Figure 5Ac ), compared with that in cell culture in the absence of Ab (Figure 5Aa ), suggesting that APRIL expression was crucially important for induction of resistance to apoptosis in T-ALL CD8 þ CD34 þ T cells by CXCL13. As shown in Figure 5B , the total fractions of dead cells (including apoptotic and necrotic) in different experimental conditions were the same patterns as the results in Figure 5A . These results could confirm the importance of APRIL expression for induction of resistance to apoptosis in T-ALL CD8 þ CD34 þ T cells by CXCL13. Recombinant human APRIL was added to TNF-a-and CXCL13-treated T-ALL CD8 þ CD34 þ in the absence or presence of mAb against CXCR5 (Table 3 ). Higher concentrations of APRIL (0.1-1 mg/ml) could in vitro indeed rescue T-ALL CD8 þ CD34 þ T cells from TNF-ainduced apoptosis in a dose-dependent manner.
CXCL13 via APRIL upregulation induces resistance to apoptosis in T-ALL CD8
Caspase-3 and -8 expression was essential for this type of cell death (Thornberry and Lazebnik, 1998). Expression levels of activated caspase-3 (Figure 6a ) and caspase-8 ( Figure 6b) were measured by intracellular staining of T-ALL CD8 þ CD34 þ T cells within the distinct cell cultures. In freshly isolated T-ALL CD8 þ CD34 þ T cells, both cleaved caspase-3 and -8 were at very low levels (11 and 15%, respectively). After stimulation with TNF-a, cleaved caspase-3 and -8 were significantly upregulated (44 and 54%, respectively). In the presence of CXCL13 in cell culture, the levels of cleaved caspase-3 and -8 in T-ALL CD8 þ CD34 þ T cells were stabilized. Ab against CXCR5 as well as Ab against APRIL could separately block the stabilizing effects of CXCL13 on caspase-3 and -8 during TNF-amediated apoptosis. The results of Western blotting also confirmed the observation (Figure 6c) . Thus, the observation suggested that CXCL13, by means of activation of frequently expressed CXCR5-induced membrane APRIL expression, subsequently stabilized caspase-3 and -8 in T-ALL CD8 þ CD34 þ T cells, and rescued the cells from TNF-a-mediated apoptosis.
The inhibitor of the apoptosis family of proteins was found to protect against the broadest spectrum of apoptotic signals (Duckett et al., 1996; Miller, 1999) . Western blot showed that the protein levels of antiapoptotic members Bcl-2, Bcl-X, and c-FLIP L in the cells under the distinct experimental conditions were identical to that in freshly isolated T-ALL CD8 þ CD34 þ T cells (Figure 6d ). Interestingly, after apoptotic induction with TNF-a and stimulation with CXCL13, the expression level of one antiapoptotic member protein in IAP family livin was significantly increased Figure 5 Analysis of apoptotic and total dead (necrotic and apoptotic) cells in T-CLL CD8 þ CD34 þ T cells. Flow cytometric analysis of apoptotic (A) and total dead cells (B), the CD8 þ CD34 þ T cells were isolated from T-ALL patients as described in Materials and methods, and were pretreated in the absence or presence of Ab(s) (or isotypes) as indicated (all at 5 mg/ml) for 6 h at room temperature, following subsequent stimulations in the presence of CXCL13 (at 100 ng/ml) for 24 h, and stimulation with TNF-a (100 ng/ml) for 24 h at 371C. APRIL Ab blocking was after CXCL13 stimulation. Ab À , without antibody block. Abs, blocking with both CXCR5 and APRIL antibodies. The cells were analysed by flow cytometry for PI-(y-axis) and FITC-conjugated annexin V (x-axis) as described in Materials and methods. The gating in the forward scatter and side scatter histograms was adhered to the lymphocyte region. The percentages of PI À annexin V þ cells and PI þ annexin V þ cells were indicated in the figure. The data (A) were from a single experiment, which was representative of five experiments performed. The data for total dead cells ( + T cells were pretreated CXCL13 (100 ng/ml) in the absence (À) or presence (+) of mAb against CXCR5 (5 mg/ml) as described in Materials and methods, followingstimulation with TNF-a (100 ng/ml) for 24 h at 371C before apoptotic assay. Apoptotic resistance via CXCR5/livin/APRIL pathway Z Qiuping et al (Figure 6d ), in comparison with that in freshly isolated cells. Ab against CXCR5 as well as Ab against APRIL could separately and significantly inhibit the elevation of expression level of livin in these cells (Figure 6d ). Other antiapoptotic members in the IAP family XIAP, c-IAP1, c-IAP2, and survivin expressed identical levels in the different conditions in T-ALL CD8 þ CD34 þ T cells (Figure 6d ). Thus livin was involved in the events of CXCR5-CXCL13-induced resistance to TNF-amediated apoptosis in T-ALL CD8 þ CD34 þ T cells.
CXCR5-CXCL13 increases resistance to apoptosis in T-ALL CD8
þ CD34 þ T
cells in a livin-dependent manner
The 293T cells were transfected with plasmids encoding CXCR5 and different combinations among wt livin, wt APRIL, mutant livin, and mutant APRIL as indicating in Figure 7 . Only the cells transfecting both wild-type livin and wild-type APRIL could be rescued by CXCL13 from TNF-a-induced apoptosis (Figure 7a ). Expression levels of activated caspase-3 and -8 were measured by intracellular staining of both wild-type 
þ T cells were isolated from T-ALL patients as described in Materials and methods, and were pretreated in the absence or presence of Ab ( þ ) (or isotypes) as indicated (all at 5 mg/ml) for 6 h at room temperature, following subsequent stimulations in the presence of CXCL13 (at 100 ng/ml) for 24 h, and stimulation with TNF-a (100 ng/ml) for 24 h at 371C. APRIL Ab blocking was after CXCL13 stimulation. They were then permeabilized and fixed as indicated in Materials and methods, and subsequently stained for intracellular activated (cleaved) caspase-3 or -8. Activated caspase-3-or -8-specific fluorescence intensity was measured by flow cytometry. The indicating percentages of cells with activated caspase-3 or -8 were quantitated from relative-frequency histograms. Isotype Ab controls were expressed as dished curves. In (c and d), The caspase-3 (upper panel) or caspase-8 (lower panel), Bcl-2, Bcl-X, and c-FLIP L , XIAP, c-IAP1, c-IAP2, survivin and livin proteins were examined using Western blot analyses. The cells, from different subjects as described above, were lysed and total protein content electrophoresed and blotted as described in Materials and methods. Actins in lower pictures indicated the quantity of total cellular protein from the tested samples loaded in each lane. Arrows indicated markers used to verify equivalent molecular weights of appropriate proteins in each lane MCF7 cells were cotransfected with vectors encoding CXCR5 and either wt APRIL and wt livin, or wt livin alone. APRIL þ livin þ and livin þ cells were mixed or separately placed in transwell chambers in culture during the procedure. As show in Table 4 , the cells in the mixed culture (APRIL þ livin þ : livin þ ¼ 1 : 1) and cotransfected cell culture (APRIL þ livin þ cells alone) were equally rescued in the presence of CXCL13, whereas livin þ cells alone could not be rescued in the presence of CXCL13. This observation strongly suggested that upregulated APRIL could link to binding sites (presumably be APRIL receptors) (Yu et al., 2000) on the neighboring cells in the culture in cell-cell contact manner to selectively activate livin, and consequently to rescue the cells. In this process, APRIL receptors might also directly activate livin.
Discussion
CXCR5 and CXCL13 play a crucial role in lymphocyte traffic within secondary lymphoid tissues, and are involved in the formation of the B-cell compartment. Mice lacking either CXCR5 or BLC (the murine homolog of human BCA-1) have gross aberrations in the follicular architecture of the spleen and reduced numbers of Peyer's patches and lymph nodes. CXCR5 Figure 7 CXCL13 requires livin and APRIL for protection against apoptosis. HEK 293T cells were cotransfected with vectors encoding CXCR5 (400 ng) and different combinations of wt livin, wt APRIL, mutant livin, and mutant APRIL (400 ng each) as indicated. The amount of transfected cDNA was kept constant in each sample by adding control pcDNA3 vector. Cells were pretreated in the absence or presence of CXCL13 (100 ng/ml) described in Materials and methods; some of the cells were stimulated with TNF-a (100 ng/ml) for 24 h at 371C before the other assay as indicated. (a) Analysis of total dead (necrotic and apoptotic) cells. The cells were analysed by flow cytometry as described in the legend for Figure 4 . The data were mean values from six experiments performed. Statistically significant difference as compared with vector transfected only was indicated (*Po0.001). (b) Flow cytometric analysis of active caspase-3 and -8 in transfected cells as indicated. Cells were pretreated as mentioned above. They were then permeabilized and fixed as indicated in Materials and methods, and subsequently stained for intracellular activated (cleaved) caspase-3 or -8. Activated caspase-3-or -8-specific fluorescence intensity was measured by flow cytometry. The percentages of cells with activated caspase-3 or -8 were quantitated from relative-frequency histograms. Isotype Ab controls were expressed as dished curves Transwell experiments were carried out in 24-well plates as described previously (Jonuleit et al., 2000) . APRIL + livin + and livin + cells were separately placed in transwell chambers (Millicell, 0.4 mm; Millipore) in culture during the procedure. d Cells were pretreated in the absence (À) or presence (+) of CXCL13 (100 ng/ml) described in Materials and methods, following stimulation with TNF-a (100 ng/ml) for 24 h at 371C before the other assay as indicated. The analysis of total dead (necrotic and apoptotic) cells. e Cells were analysed by flow cytometry as described in the legend for Figure 3 . The data were mean values from six experiments performed. f Statistically significant differences were compared between the absence and presence of CXCL13 (*Po0.001) Apoptotic resistance via CXCR5/livin/APRIL pathway Z Qiuping et al and CXCL13 are not strictly obligatory for cellular and humoral immune responses (Voigt et al., 2000) . CXCR5 is expressed uniformly on B cells, except plasma cells (Hargreaves et al., 2001) . CXCR5 is expressed on a subset of peripheral blood and tonsillar memory CD4 þ T cells, but is absent from naı¨ve CD4 þ T cells, and Th1 and Th2 cells (Breitfeld et al., 2000; Kim et al., 2001) . In the present study, we have investigated four different types of cells, for example,
, and CD8 þ CD34 À T cells from normal CB, T-ALL, and T-CLL patients in terms of expression and functions of CXCR5. We have found that CXCR5 is selectively frequently expressed on T-ALL CD8 þ CD34 þ T cells. CXCL13 selectively induces resistance to apoptosis in T-ALL CD8 þ CD34 þ T cells. Chemokine ligand-receptor signaling is able to provide antiapoptotic activity to hematopoietic cells (Han et al., 1997; Scheuerer et al., 2000; Youn et al., 2001 Youn et al., , 2002 . However, there are some controversial even contradictory reports, such as CXCR4 induces programmed cell death of human peripheral CD4 þ T cells, malignant T cells, and CD4/CXCR4 transfectants (Berndt et al., 1998) . The interaction between HIV R5 Env and CCR5 activates the Fas pathway and caspase-8 as well as triggering FasL production, ultimately causing CD4 þ Tcell death (Algeciras-Schimnich et al., 2002) . CCR3 expression induced by IL-2 and IL-4 functions as a death receptor for B cells . The results in this study, together with other observations, suggest that normal lymphocytes utilize CXCR5/ CXCL13 for migration, homing, development, maturation, selection, and cell homeostasis, as well as secondary lymphoid tissue organogenesis. Meanwhile, some malignant cells, particularly T-ALL CD8 þ CD34 þ T cells, take advantages of CXCR5/CXCL13 for infiltration, resistance to apoptosis, and inappropriate proliferation. To our knowledge, this study is the first report on differential functions of CXCR5/CXCL13 in distinct types of cells in terms of induction of apoptotic resistance, and is the direct evidence of the pathophysiological activity of T-ALL CD8 þ CD34 þ T cells induced by CXCL13.
APRIL-transfected cells and addition of APRIL to cells increase their proliferation and in vitro growth rate, and enhance tumor growth rate in nude mice (Hahne et al., 1998) . B-cell maturation antigen (BCMA), an APRIL receptor, blocks the growth of APRIL-expressing cell lines in nude mice (Rennert et al., 2000) . T cells from APRIL transgenic (Tg) mice show increased proliferation and elevated IL-2 production (Stein et al., 2002) , suggesting APRIL as an in vitro T-cell stimulator (Yu et al., 2000; Siegel and Lenardo, 2001) . A highly significant increase in vitro survival of Tg APRILexpressing T cells is also observed (Medema et al., 2003) . A genetic change that leads to blocking apoptosis may allow a cell to acquire further mutations, survive inappropriately, and eventually become malignant. Additionally, a defect in the inherent ability of a cell to undergo apoptosis may account for much of the resistance to different therapies observed in leukemic cells. Therefore, much effort has gone into understanding how apoptosis is altered in leukemia cells and how it can be modulated to overcome resistance and improve clinical outcomes. In the present study, with sufficient and direct data we have managed to show that CXCL13 selectively increases APRIL expression in T-ALL CD8 þ CD34 þ T cells to induce resistance to apoptosis in a livin-dependent manner. Livin is a potent antiapoptotic protein and not detectable in most normal adult tissues. Elevated expression of livin renders melanoma cells resistant to apoptotic stimuli and potentially contributes to the pathogenesis of this malignancy (Vucic et al., 2000) . Our findings, together with others, indicate that APRIL and livin may be some critical cellular factors whose increased expression confers resistance to apoptotic stimuli, thereby contributing to the pathogenesis and progression of malignant cells such as melanoma cells, and T-ALL CD8 þ CD34 þ T cells. The TWE-PRIL is a functional membrane-bound TWEAK-APRIL fusion protein and shares the same receptor-binding domain with APRIL (Rennert et al., 2000; Pradet-Balade et al., 2002) . In the present study, we have observed that only higher concentrations of APRIL can in vitro rescue cells from apoptosis (Table 3) . CXCL13 rescues APRIL-and livin-cotransfected cells in cell-cell contact manner (Table 4) . Taking into account the same expression patterns of TWE-PRIL as APRIL after stimulation with CXCL13 (Figure 4f ), we presume that CXCL13 in real life needs functional synergy of APRIL and TWE-PRIL to rescue cells from apoptosis. The exact mechanism should be subjected to further investigation.
Materials and methods
Patients and cell purification
All patients with T-ALL or T-CLL were diagnosed according to The French-American-British (FAB) Cooperative Group criteria (Bennett et al., 1981) or to the guidelines of the National Cancer Institute Working Group on B-CLL (Bennett et al., 1989; Cheson et al., 1996) . All patients gave informed consent according to institutional guidelines. CD4
þ CD34 þ cells were purified PBMCs as described elsewhere (Jinquan et al., 2000; Qiuping et al., 2003) . After enrichment of PBMCs by LymphPrept gradient, CD4 þ , or CD8 þ CD34 þ , double-positive cells were sorted using a FACSstarPlus and FITC-or PE-conjugated antibodies (BD Pharmingen) against CD4, CD8, and CD34 from cord blood (CB) of uncomplicated births or patients with T-ALL or T-CLL. The malignancy of purified T-ALL or T-CLL CD4 þ or CD8 þ CD34 þ cells was checked by expression of CD25, CD45RO, and HLA-DR (Qiuping et al., 2003) . The cell lines were human embryonic kidney 293T cells and MCF7-Fas cells (from the American Type Culture Collection, Manassas, VA, USA). The a-CXCR5mAb and chemokines (CXCL13, CCL25, and CXCL12) were purchased from R&D Systems, Abingdon, UK.
Flow cytometry
For detection of the chemokine receptor, the cells were triplestained PE-labeled CD4 or CD8, FITC-labeled CD34 (DAKO, Denmark), and PerCP-labeled chemokine receptor antibody (R&D Systems, Abingdon, UK) at 5 mg/ml in PBS for 20 min, followed washing twice in staining buffer (Qiuping et al., 2003) . For detection of apoptosis, cells were stained in staining medium with 1 mg/ml propidium iodide (PI) for 30 min at 41C, then stained with FITC-conjugated annexin V with binding buffer (BD Pharmingen) (Youn et al., 2001; Jinquan et al., 2003) . For detection of intracellular active caspases, cytofix/cytoperm buffer (BD Pharmingen) was used to permeabilize cells, and cells were subsequently stained with anti-active-capsase-3 or anti-active-caspase-8mAb (BD Pharmingen). The measurements were performed with a flow cytometer (COULTER 
Real-time quantitative reverse transcription (RT)-PCR assay
All real-time quantitative RT-PCR reactions were performed as described elsewhere (Kruse et al., 1997) . Briefly, total RNA from purified cells (1 Â 10 5 , purity >99%) was prepared by using Quick Prep s total RNA extraction kit (Pharmacia Biotech, USA). RNA was reverse transcribed by using oligo(dT) [12] [13] [14] [15] [16] [17] [18] 0 -TTCGATCAATGAAGCGTCTAGG-3 0 . All unknown cDNAs were diluted to contain equal amounts of b-actin cDNA. PCR retaining conditions were 2 min at 501C, 10 min at 951C, 40 cycles with 15 s at 951C, and 60 s at 601C for amplifications.
Northern and Western blot assays
For mRNA detection (Northern blot), as previously described (Sica et al., 1997) , 5 mg of total RNA was electrophoresed under denaturing conditions, followed by blotting onto Nytran membranes, and crosslinked by UV irradiation. CXCR5 cDNA probes were obtained by PCR amplification of the sequence mentioned above from total RNA from PBMC from normal adults. The membranes were hybridized overnight with 1 Â 10 6 c.p.m./ml of 32 P-labeled probe, followed by intensive washing with 0.2 Â SSC and 0.1% SDS before being autoradiographed. For protein detection (Western blot), the cells were lysed in lysis buffer (Massari et al., 2000) . Cell lysis was performed for 30 min at 41C with lysis buffer. Lysates were centrifuged at 10 000 r.p.m. for 5 min at 41C. Protein (around 40 mg) was loaded onto 16% SDS-PAGE, transferred onto PVDF membranes after electrophoresis, and incubated with the appropriate Abs at 0.5 mg/ml. Analyses were conducted using enhanced chemiluminescence detection (Amersham Pharmacia Biotech, Little Chalfont, UK). All Abs (APRIL, Bcl-2, Bcl-X, c-FLIP L , c-IAP1, c-IAP2, XIAP, and survivin) were from Santa Cruz Biotech Inc., Santa Cruz, CA, USA, except for a-livin mAb from Imgenex Corp., Sorrento Valley, San Diego, USA, and a-b-actin mAb from Sigma Chemical Co.
Chemotaxis assay
The chemotaxis assay was performed in a 48-well microchamber (Neuro Probe, Bethesda, MD, USA) technique (Qiuping et al., 2003) . Briefly, chemokines in RPMI 1640 with 0.5% BSA were placed in the lower wells (25 ml). A measure of 25 ml cell suspension (2 Â 10 6 cells/ml) was added to the upper well of the chamber, which was separated from the lower well by a 5 mm pore size, polycarbonate, polyvinylpyrolidone-free membrane (Nucleopore, Pleasanton, CA, USA). The chamber was incubated for 60 min at 371C and 5% CO 2 . The membrane was then carefully removed, fixed in 70% methanol, and stained for 5 min in 1% Coomassie brilliant blue. The migrating cells were counted using light microscopy. Approximately 6% of the cells will migrate spontaneously (known as MCNC). The results were expressed as chemotactic index (C.I.) with standard deviation (s.d.).
Adhesion assays
As described previously (Qiuping et al., 2003) , 96-well plates were coated with laminin (20 mg/ml, Sigma Chemical Co.) in PBS for 1 h at 371C. Plates were washed with PBS and incubated with medium containing 0.2% BSA for 1 h to block nonspecific adhesion. The single-cell suspensions (4 Â 10 5 cells/ml) with 0.2% BSA were added to the appropriate chemokine. The cell suspension was added 100 ml/well in triplicate to the plates, and incubated for 60 min at 371C. The wells were then washed with 0.2% BSA in PBS, followed by careful aspiration. Subsequently, the adherent cells were fixed with 1% formaldehyde and stained with 1% crystal violet. Crystal violet was then extracted by the addition of a 1 : 1 mixture of sodium citrate (0.1 M) and ethanol (pH 4.2). The absorbency was then read at 540 nm. Background cell adhesion to 2% BSA-coated wells was subtracted from all readings.
Plasmids and cell transfection
Plasmids encoding CXCR5, livin, and APRIL and the catalytically inactive mutants livin and APRIL (RKRR motif deletion) used in this study have been described previously (Kanbe et al., 1999; Rennert et al., 2000; Vucic et al., 2000; Lopez-Fraga et al., 2001) . The cells were transiently transfected with vectors encoding target genes as described elsewhere. Briefly, the cells were cultured with DMEM containing 10% FCS, penicillin, and streptomycin. Cells were grown to approximately 70% confluence in 60-mm dishes for 24 h before transfection. The DNA construct of expression vectors (0.4 mg) or vector only was mixed with 12 ml of LipofectAMINE (Gibco BRL) in 2 ml of opti-DMEM serum-free medium and added to cells, and incubated for 6 h. The cells were further cultured in 2.5 ml of DMEM containing 10% FCS in 5% CO 2 .
Abbreviations APRIL, A proliferation-inducing ligand; BCA-1, B-cell attracting chemokine 1; BCMA, B-cell maturation antigen; C.I., chemotactic index; CXCL (CC), CXC (CC) chemokine ligand; CXCR (CC), CXC (CC) chemokine receptor; T-ALL (T-CLL), T-cell-lineage acute (chronic) lymphocytic leukemia.
